Innoviva, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Burlingame, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Innoviva, Inc. has filed 1,661 SEC EDGAR filings since 21 Mar 2000

SEC filing history

Showing 976-1,000 of 1,000 matching filings.

Per page
25
Current page
40
4

FORM 4 -

Filing date
11 Feb 2013
Reporting date
07 Feb 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
11 Feb 2013
Reporting date
07 Feb 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-80415

THRX AS OF 12/31/2012

Filing date
06 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

8-K

Filing date
25 Jan 2013
Reporting date
24 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

8-K

Filing date
23 Jan 2013
Reporting date
17 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-186058

424B5

Filing date
18 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-186058

FWP

Filing date
18 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-186058

FWP

Filing date
18 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-186058

FWP

Filing date
16 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

8-K

Filing date
16 Jan 2013
Reporting date
16 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-186058

FWP

Filing date
16 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-186058

S-3ASR

Filing date
16 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
14 Jan 2013
Reporting date
11 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

THERAVANCE, INC. 8K

Filing date
09 Jan 2013
Reporting date
09 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

THERAVANCE, INC. 8-K

Filing date
18 Dec 2012
Reporting date
18 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

8-K

Filing date
14 Dec 2012
Reporting date
14 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
06 Dec 2012
Reporting date
04 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

THERAVANCE, INC. 8-K

Filing date
29 Nov 2012
Reporting date
29 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

8-K

Filing date
27 Nov 2012
Reporting date
27 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
20 Nov 2012
Reporting date
20 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
20 Nov 2012
Reporting date
20 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
20 Nov 2012
Reporting date
20 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
16 Nov 2012
Reporting date
14 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
06 Nov 2012
Reporting date
02 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Nov 2012
Reporting date
02 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .